Phio pharma stock
Webb29 mars 2024 · With Phio Pharmaceuticals stock trading at $5.68 per share, the total value of Phio Pharmaceuticals stock (market capitalization) is $6.54M. Phio Pharmaceuticals stock was originally listed at a price of $257,400.10 in May 10, 2012. If you had invested in Phio Pharmaceuticals stock at $257,400.10, your return over the last 10 years would … Webb10 apr. 2024 · Phio Pharmaceuticals. Phio Pharmaceuticals Corp. is a biotechnology company, which engages in the development of immuno-oncology therapeutics that address unmet medical needs. Its clinical product candidate includes RXI-109, a RNAi compound developed for the reduction of dermal scarring in planned surgeries.
Phio pharma stock
Did you know?
Webbför 15 timmar sedan · The global rnai technology market is expected to experience strong growth between 2024 and 2030, with a CAGR of 10.1%. The market was valued at US$ 1,783.5 Mn in 2024 and is forecast to reach a ... Webb28 feb. 2024 · View the latest Phio Pharmaceuticals Corp. (PHIO) stock price, news, historical charts, analyst ratings and financial information from WSJ. PHIO Phio …
Webb10 apr. 2024 · Summary of all time highs, changes and price drops for Phio Pharmaceuticals; Historical stock prices; Current Share Price: US$5.71: 52 Week High: … Webb6 jan. 2024 · Phio is a clinical stage biotechnology company whose proprietary INTASYL™ RNAi technology is designed to make immune cells more effective in killing tumor cells. Phio's PH-762 is an INTASYL...
Webb7 apr. 2024 · See the latest Phio Pharmaceuticals Corp stock price (NASDAQ:PHIO), related news, valuation, dividends and more to help you make your investing decisions. http://www.foxchart.com/index.php?symbol=PHIOW
Webb3 apr. 2024 · Phio Pharmaceuticals Corp is a US-based biotechnology company. It is principally engaged in developing immuno-oncology therapeutics based on its …
Webb15 apr. 2016 · At the effective time of the reverse stock split, every ten (10) shares of RXi Pharmaceuticals common stock will be combined into one (1) share of RXi … bing weekly news uyyWebbFoxChart.com Stock quote, stock technical analysis, stock charts. Phio Pharmaceuticals Corp. (PHIOW) 0.0232 0.006 (36.47%) 12-21 15:56: Open: 0.131574: High: 0.0273: Low: ... Phio Pharmaceuticals has collaboration with AgonOx Inc. on clinical development of novel T cell-based cancer immunotherapies. dac disabled adult childWebb10 apr. 2024 · The Phio Pharmaceuticals Corp. stock price fell by -3.15% on the last day (Monday, 10th Apr 2024) from $5.71 to $5.53.During the last trading day the stock fluctuated 0.90% from a day low at $5.53 to a day high of $5.58.The price has fallen in 7 of the last 10 days and is down by -3.16% for this period. Volume fell on the last day along … bing weekly news y6WebbUNDERWRITER COMMON STOCK PURCHASE WARRANT PHIO Pharmaceuticals Corp. Document Metadata. Filed: January 31st, 2024. Country United States; Jurisdiction New York; Industry Pharmaceutical preparations; Company Phio Pharmaceuticals Corp. SEC Filing ID 0001683168-20-000317; SEC Filing Type s-1-a; SEC Exhibit ID ex-4; dac crypto currencyWebb31 dec. 2024 · 提供Phio Pharmaceuticals Corp.(PHIOW)財報，包含歷年及最新發布的財務報表數據及分析。您可按季報，中報，年報查詢，還可方便地比較歷史數據。 bing weekly news tttWebb免費提供Phio Pharmaceuticals Corp.(PHIOW)公告，包括公司最新公布的專項披露公告，定期披露文件，翌日披露報表，股份發行人的證券變動月報表等公告。 bing weekly news quiz tonightWebb22 mars 2024 · Phio Pharmaceuticals Corp. (Nasdaq: PHIO) is a clinical stage biotechnology company whose proprietary INTASYL™ RNAi technology is designed to … bing weekly news yuyyy